Cerus Company Profile

15:39 EDT 25th September 2018 | BioPortfolio

At Cerus Corporation we have developed a platform technology (Helinx®) that prevents nucleic acid (DNA and RNA) replication. The Company's initial application of this technology is the development of the INTERCEPT Blood Systems to inactivate viruses, bacteria and other pathogens in the blood components used for transfusion - platelets, plasma and red blood cells.


2411 Stanwell Drive
United States of America


Phone: (925) 288-6000
Fax: (925) 288-6001

News Articles [28 Associated News Articles listed on BioPortfolio]

Cerus gains $15M from contract amendment to support blood transfusion studies

An expanded agreement between HHS' Biomedical Advanced Research and Development Authority and Cerus will provide an additiona -More- 

Cerus to Present at the Baird 2018 Global Healthcare Conference

Cerus Corporation (Nasdaq: CERS) today announced that Kevin D. Green, Cerus’ vice president, finance and chief financial officer, will present and provide a corporate update at ...

Cerus to Present at the Deutsche Bank 43rd Annual Health Care Conference on Wednesday May 9, 2018

Cerus Corporation (Nasdaq: CERS) announced today that Dr. Laurence M. Corash, co-founder and chief scientific officer, and Lainie Corten, vice president of global marketing, are s...

Cerus to Release First Quarter 2018 Results on May 8, 2018

Cerus Corporation (Nasdaq:CERS) announced today that its first quarter results will be released on Tuesday, May 8, 2018, after the close of the stock market. The company will host...

Cerus to Release Second Quarter 2018 Results on August 2, 2018

Cerus Corporation (Nasdaq:CERS) announced today that its second quarter results will be released on Thursday, August 2, 2018, after the close of the stock market. The company will...

Health Canada approves Cerus’ Intercept blood system for platelets

Cerus announced that Health Canada has approved the commercialization of Intercept blood system for platelets.

Cerus Appoints Timothy L. Moore to Board of Directors

Cerus Corporation (Nasdaq:CERS) today announced the appointment of Timothy L. Moore to its Board of Directors. Mr. Moore, who currently serves as executive vice president, technic...

Cerus' (CERS) CEO Obi Greenman on Q1 2018 Results - Earnings Call Transcript

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Synthesis, antibacterial activity, synergistic effect, cytotoxicity, docking and molecular dynamics of benzimidazole analogues.

A series of 2-Cl-benzimidazole derivatives was synthesized and assessed for antibacterial activity. Antibacterial results indicated that compounds 2d, 2e, 3a, 3b, 3c, 4d and 4e showed promising activi...

Molecular modeling, synthesis, antibacterial and cytotoxicity evaluation of sulfonamide derivatives of benzimidazole, indazole, benzothiazole and thiazole.

A new series of heterocyclic molecules bearing sulfonamide linkage has been synthesized and screened for antibacterial activity. During antibacterial screening using broath dilution method, molecules ...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Contour Neurovascular System - European Pre-Market Unruptured Aneurysm

Cerus Endovascular is sponsoring a prospective, multi-center trial to document the safety and performance of the Contour Neurovascular System™ ("Contour"). The purpose of the study is t...

Companies [3 Associated Companies listed on BioPortfolio]


At Cerus Corporation we have developed a platform technology (Helinx®) that prevents nucleic acid (DNA and RNA) replication. The Company's initial application of this technology is the development o...

Cerus Corporation and SunCoast Blood Bank

Cerus Corporation

Condensed Consolidated Unaudited Balance Sheets

More Information about "Cerus" on BioPortfolio

We have published hundreds of Cerus news stories on BioPortfolio along with dozens of Cerus Clinical Trials and PubMed Articles about Cerus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cerus Companies in our database. You can also find out about relevant Cerus Drugs and Medications on this site too.

Quick Search


Relevant Topics

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Corporate Database Quicklinks

Searches Linking to this Company Record